e-learning
resources
Glasgow 2004
Sunday 05.09.2004
Animal models of lung injury and repair
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
IL-9 protects against bleomycin-induced lethal lung injury through a prostaglandin-dependent mechanism
M. Arras, J. Louahed, J. F. Heilier, J. C. Renauld, D. Lison, F. Huaux (Brussels, Belgium)
Source:
Annual Congress 2004 - Animal models of lung injury and repair
Session:
Animal models of lung injury and repair
Session type:
Thematic Poster Session
Number:
739
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Arras, J. Louahed, J. F. Heilier, J. C. Renauld, D. Lison, F. Huaux (Brussels, Belgium). IL-9 protects against bleomycin-induced lethal lung injury through a prostaglandin-dependent mechanism. Eur Respir J 2004; 24: Suppl. 48, 739
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Kallistatin protects against LPS-induced mouse lung injury
Source: Annual Congress 2012 - The many roads to lung injury
Year: 2012
Ghrelin ameliorates bleomycin-induced acute lung injury by protecting alveolar epithelial cells and suppressing lung inflammation
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012
Rikkunshito ameliorates bleomycin-induced lung injury in mice
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012
Effects of autophagy on LPS-induced lung inflammation and acute lung injury (ALI) in vitro and in vivo
Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury
Year: 2018
TNF neutralization ameliorates urethane-induced lung carcinogenesis
Source: Annual Congress 2011 - Progress in pathology of lung cancer
Year: 2011
Role of proinflammatory cytokines IL-18 and IL-1β in bleomycin-induced lung injury in humans and mice
Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis
Year: 2009
Induction of antioxidant defense mechanisms by amifostine in lung tissue attenuates ventilator induced lung injury
Source: Annual Congress 2010 - New insights into reactive oxygen species
Year: 2010
Chronic intermittent hypoxia exacerbates lung fibrosis in bleomycin-induced lung injury mouse model
Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities
Year: 2018
Ghrelin protects against bleomycin-induced pulmonary fibrosis in mice
Source: International Congress 2017 – Lung fibrosis: basic science
Year: 2017
PD98059 attenuates the development of bleomycin-induced lung injury and fibrosis
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010
PKA- and Epac/Rap-dependent mechanisms of lung endothelial barrier protection in acute lung injury
Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury
Year: 2009
The role of pendrin in acute lung injury caused by ventilator-induced lung injury
Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Year: 2020
Dexamethasone inhibits surfactant degradation during bleomycin-induced lung injury in rats
Source: Eur Respir J 2006; 28: Suppl. 50, 855s
Year: 2006
Enhanced lung inflammatory response to intratracheal CpG-ODN in mice with bleomycin-induced lung fibrosis
Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases
Year: 2011
Inhaled activated protein C protects mice from ventilator-induced lung injury
Source: Annual Congress 2009 - Acute lung injury: biological mechanisms
Year: 2009
Rho-kinase inhibitor ameliorates bleomycin-induced chronic lung injury in neonatal rats
Source: Annual Congress 2011 - Issues in paediatric and neonatal intensive care
Year: 2011
N-acetyl-L-cysteine modify prostanoids levels in bleomycin-induced lung injury
Source: Eur Respir J 2002; 20: Suppl. 38, 489s
Year: 2002
The PD-1 immune checkpoint promotes lung damage in murine models of COPD-like inflammation
Source: International Congress 2019 – Injury and repair: less is more
Year: 2019
Ethyl pyruvate prevents lung injury through inhibition of the NF-kappa B pathway, but does not prevent bleomycin-induced lung injury
Source: Annual Congress 2010 - New insights into reactive oxygen species
Year: 2010
The role of osteopontin in the pulmonary fibrosis caused by acute lung injury induced by lipopolysaccharide in rats
Source: Annual Congress 2011 - Acute respiratory failure
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept